Skip to main content
. 2013 Jan 25;18(2):1564–1581. doi: 10.3390/molecules18021564

Figure 2.

Figure 2

Structures of antifungal compounds examined in this study. (a) KA, (b) AntA, (c) Kre-Me, and (d) PCS; (e) Scheme for enhancement of antifungal activities of complex III inhibitors by KA-mediated chemosensitization.